Cross-linked antioxidant nanozymes for improved delivery to CNS
about
Nanostructures for peroxidasesBridge between neuroimmunity and traumatic brain injuryAntioxidant-based therapies for angiotensin II-associated cardiovascular diseasesPolymeric Nanostructures for Imaging and TherapyConjugates of superoxide dismutase 1 with amphiphilic poly(2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and in vivoMacrophages offer a paradigm switch for CNS delivery of therapeutic proteins.Neuronal uptake of nanoformulated superoxide dismutase and attenuation of angiotensin II-dependent hypertension after central administration.Agile delivery of protein therapeutics to CNSSOD1 nanozyme salvages ischemic brain by locally protecting cerebral vasculature.Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeuticsSuperoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation.Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.Well-defined cross-linked antioxidant nanozymes for treatment of ischemic brain injuryShell-crosslinked knedel-like nanoparticles induce lower immunotoxicity than their non-crosslinked analogs.Surface charges and shell crosslinks each play significant roles in mediating degradation, biofouling, cytotoxicity and immunotoxicity for polyphosphoester-based nanoparticles.Differential immunotoxicities of poly(ethylene glycol)- vs. poly(carboxybetaine)-coated nanoparticles.Strategies for delivery of therapeutics into the central nervous system for treatment of lysosomal storage disorders.Targeted interception of signaling reactive oxygen species in the vascular endotheliumNanocarrier: a potential tool for future antioxidant therapy.
P2860
Q26782807-AE6D4D29-CD80-4971-A821-6E25F42E3B7AQ26827612-7B2CDDAF-435A-4CDE-9BC1-2ADF5E835F72Q27016563-AAAA0412-10BF-47A3-9689-98A79CCDA94CQ30372383-C17F6435-3617-4D8C-9CEE-4435B530E285Q30535357-E3C929E4-9AFF-4F25-87FC-1D861017140BQ33631069-215191B5-3CB0-4427-883B-3CE572C6F5B8Q33978310-5B843DD3-6D84-4FF7-936C-CDBE0076E7AEQ34079647-55919A87-939F-47D0-A522-50FC8604B9C0Q34481558-C30E64E3-F89D-4900-9998-E895E06159C9Q36035550-1F970863-8614-441E-B818-DA0D1994E103Q36369061-66AA9E44-3430-43FF-AB8A-C45DB968C7D2Q36392586-4AD8ED03-FF69-4886-978E-583DBDE5AE44Q36684451-BAE41F26-E372-4DD8-BAD3-0E518ECA7831Q37265121-6306E259-7D85-4DB3-9BE8-0927E0972529Q37334228-5572B0CE-25AD-4BF5-B20D-7B6959041A04Q37381547-7C96874E-701A-4308-923B-F9487C303E75Q37672410-E01F7BA8-93EC-46B9-954B-A8947AFDFF8DQ38029695-1866857D-F4FE-4D69-9105-D19E17E268BDQ38213492-5537917A-8971-4820-94AA-76001B7BAA9F
P2860
Cross-linked antioxidant nanozymes for improved delivery to CNS
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cross-linked antioxidant nanozymes for improved delivery to CNS
@ast
Cross-linked antioxidant nanozymes for improved delivery to CNS
@en
type
label
Cross-linked antioxidant nanozymes for improved delivery to CNS
@ast
Cross-linked antioxidant nanozymes for improved delivery to CNS
@en
prefLabel
Cross-linked antioxidant nanozymes for improved delivery to CNS
@ast
Cross-linked antioxidant nanozymes for improved delivery to CNS
@en
P2093
P2860
P1476
Cross-linked antioxidant nanozymes for improved delivery to CNS
@en
P2093
Alexander V Kabanov
Anna M Brynskikh
Devika S Manickam
Elena V Batrakova
Natalia L Klyachko
Sheila M Higginbotham
Svetlana V Uglanova
Tatiana K Bronich
P2860
P304
P356
10.1016/J.NANO.2011.05.010
P577
2011-07-29T00:00:00Z